AR and neoplasm: Although preclinical data suggested blockage of AR signaling is promising to inhibit proliferation of these tumor cells, less is known about the exact mechanism, and thus it remains a challenge in blocking androgens/AR signaling pathways in therapeutic strategies against non-reproductive cancers.